financetom
Business
financetom
/
Business
/
Chevron to proceed with Hess takeover after winning Exxon Guyana legal battle
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Chevron to proceed with Hess takeover after winning Exxon Guyana legal battle
Jul 18, 2025 4:22 AM

HOUSTON (Reuters) -Chevron will proceed with its $53 billion acquisition of Hess, after it prevailed in a landmark legal battle against larger rival Exxon Mobil to gain access to the largest oil discovery in decades.

It is vindication for CEO Mike Wirth's strategy and a critical win since Hess' most attractive asset is its stake in the prolific Stabroek Block off the coast of Guyana, which holds more than 11 billion barrels of oil, a source of growth as Chevron works to turn around its lagging performance. 

Shares of Chevron rose 3.6% in premarket trading, while those of Hess jumped 7.4%. Exxon shares were marginally lower.

"We disagree with the International Chamber of Commerce (ICC) panel's interpretation but respect the arbitration and dispute resolution process," Exxon said in a statement.

"Given the significant value we've created in the development of the Guyana resource, we believed we had a clear duty to our investors to consider our preemption rights to protect the value we created through our innovation and hard work at a time when no one knew just how successful this venture would become," the company added.

There is no appeals process at the International Chamber of Commerce, the court that oversaw the arbitration case. Exxon said in its statement that it respects the arbitration and dispute resolution process.

CNBC first reported the arbitration outcome. An Exxon Mobil spokesperson confirmed to Reuters that Chevron prevailed in the mediation over Guyana oil assets.

Chevron, Hess and CNOOC did not immediately respond to Reuters' requests for comment.

Exxon, which operates the Stabroek Block with a 45% interest, and China's CNOOC, which holds 25%, filed arbitration claims against their partner Hess last year, arguing they had a contractual right-of-first-refusal to buy Hess' 30% interest in the joint venture. Chevron and Hess claimed the pre-emptive right did not apply to the sale of the entire Hess company. 

The claims from Exxon and CNOOC kicked off a legal battle that delayed Chevron's acquisition by at least a year and captured the attention of the global oil industry, shareholders and attorneys who craft joint operating agreements that govern oil partnerships around the world. 

The dispute likely centered on the interpretation of just several words in the confidential joint operating agreement between Exxon, Hess and CNOOC, experts told Reuters.

During a conference in May, an Exxon executive said the company worked with Chevron around the world and would do so in Guyana if the arbitrators ruled against Exxon's claim.

The fight illustrates the value of the Stabroek Block, which drove profits for the Exxon-led consortium that controls all of its oil output, transformed Guyana into one of the world's fastest-growing economies and still has potential for further oil discoveries. 

Hess' earnings from Guyana rose to $3.1 billion last year from $1.9 billion in 2023. 

Chevron's adjusted earnings last year totaled $18.3 billion, down from $24.7 billion in 2023.

Even as it awaited the arbitration verdict, Chevron was making preparations so it could close the deal within 48 hours of resolving the arbitration and complete other operational tasks within 45 days, Reuters previously reported. 

(Reporting by Sheila Dang in Houston and Arunima Kumar in Bengaluru; Editing by Anil D'Silva)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved